H-D-Leu-Thr-Arg-PNA

H-D-Leu-Thr-Arg-PNA, also known as a peptide nucleic acid (PNA) conjugate incorporating the amino acids leucine, threonine, and arginine, is a synthetic molecule that merges the unique properties of both peptides and nucleic acids. Characterized by a pseudo-peptide backbone, this compound exhibits remarkable stability against enzymatic degradation and demonstrates superior hybridization specificity toward complementary nucleic acid sequences. The presence of the Leu-Thr-Arg tripeptide motif enhances its solubility and facilitates targeted interactions, making it an attractive candidate for a wide range of research applications. As a result, H-D-Leu-Thr-Arg-PNA is highly valued in molecular biology laboratories, genetic research, and biotechnological development, where it serves as a versatile tool for exploring gene regulation, molecular diagnostics, and biomolecular engineering.

Antisense and Antigene Technologies: As a potent antisense molecule, H-D-Leu-Thr-Arg-PNA can be designed to bind selectively to specific RNA or DNA sequences, thereby modulating gene expression at the transcriptional or translational level. Its resistance to nucleases and proteases ensures prolonged activity within cellular environments, enabling researchers to achieve effective gene silencing or activation in vitro. This property is particularly advantageous for elucidating gene function, validating genetic targets, and investigating the molecular mechanisms underlying various biological processes. The peptide component further enhances cellular uptake, broadening its utility in diverse experimental systems.

Molecular Diagnostics: In the field of molecular diagnostics, the PNA-peptide conjugate is widely utilized as a hybridization probe for the detection of single nucleotide polymorphisms (SNPs), mutations, and pathogen-specific genetic sequences. Its high binding affinity and sequence discrimination capabilities allow for the development of robust assays with minimal background interference. By incorporating H-D-Leu-Thr-Arg-PNA into fluorescence in situ hybridization (FISH), microarray platforms, or real-time PCR assays, researchers can achieve sensitive and specific detection of genetic variations, which is essential for research in genomics, infectious disease studies, and personalized medicine approaches.

Biosensor Development: The unique physicochemical properties of this PNA conjugate make it an ideal recognition element in the construction of biosensors. By immobilizing it on sensor surfaces, scientists can create highly selective platforms for the detection of target nucleic acids or proteins. The peptide moiety can be engineered to facilitate oriented attachment or to mediate additional molecular interactions, thereby improving the sensitivity and selectivity of the biosensor. Applications in this direction include environmental monitoring, food safety testing, and rapid detection of genetic markers in research samples.

Molecular Imaging: H-D-Leu-Thr-Arg-PNA can be labeled with various reporter groups, such as fluorescent dyes or radiolabels, to enable real-time visualization of nucleic acid targets in living cells or tissues. Its exceptional stability and target specificity minimize background signal and enhance imaging resolution, supporting advanced studies in molecular and cell biology. The conjugation of the peptide sequence may further assist in cellular delivery, ensuring efficient probe localization and signal generation. This application is particularly valuable for tracking gene expression dynamics, monitoring intracellular processes, and validating molecular targets in situ.

Therapeutic Research Tools: In addition to its diagnostic and analytical roles, the PNA-peptide conjugate is increasingly explored as a research tool in the development of novel therapeutic strategies. Its ability to disrupt pathogenic nucleic acid interactions or modulate regulatory elements makes it a promising candidate for studying the molecular basis of genetic disorders and for evaluating innovative gene-targeted interventions. The Leu-Thr-Arg sequence can be modified to tailor cellular uptake and biodistribution, enabling researchers to optimize delivery and efficacy in preclinical models. By leveraging these attributes, H-D-Leu-Thr-Arg-PNA continues to advance the frontiers of genetic research and molecular biotechnology.

1. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

5. Cationic cell-penetrating peptides are potent furin inhibitors